[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352372-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352372-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","activating-kras-mutations-mark-premalignant-cystic-structures-in-congenital-pulmonary-airway-malformations","Activating KRAS mutations mark premalignant cystic structures in congenital pulmonary airway malformations","","Congenital Pulmonary Airway Malformations (CPAM) can undergo malignant degeneration, leading many surgeons to recommend resection even for asymptomatic patients. Prior work identified KRAS mutations in a subset of CPAM cases, suggesting a pre-malignant state. This study unifies risk assessment by testing whether KRAS mutations mark malignancy risk using patient-derived airway organoids, single-cell RNA sequencing, and KRAS expression manipulation to evaluate cellular composition, proliferation, and cell-cycle effects.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/activating-kras-mutations-mark-premalignant-cystic-structures-in-congenital-pulmonary-airway-malformations/352372/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/activating-kras-mutations-mark-premalignant-cystic-structures-in-congenital-pulmonary-airway-malformations/352372.png","ImageObject",300,407,{"name":42,"@type":43},"Liam","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why do surgeons often resect CPAM lesions even in asymptomatic patients?","Question",{"text":63,"@type":64},"CPAM may undergo malignant degeneration, so many surgeons opt for resection despite the absence of symptoms to reduce future cancer risk.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the study designed to assess KRAS as a risk factor in CPAM?",{"text":68,"@type":64},"Resected CPAM lung tissue was separated into cyst (affected) and control (non-affected) regions, followed by initiation of airway organoids. Organoids from patients with and without KRAS mutations were profiled using single-cell RNA sequencing and validated by immunofluorescent staining, with KRAS expression manipulation to determine functional effects.",{"name":70,"@type":61,"acceptedAnswer":71},"What main findings link KRAS mutations to premalignant CPAM features?",{"text":72,"@type":64},"Single-cell RNA sequencing showed altered cell proportions in KRASPOS cyst organoids compared with KRASNEG, and differentially expressed genes resembled those in KRAS-mutant lung cancer. KRAS manipulation increased organoid growth by promoting proliferative cells and directly affected the cell cycle, supporting higher malignancy risk in KRAS-mutant CPAM cysts.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352372,1790795427,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108,"preview_page_count":33,"preview_urls":145},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","van Horik etal. Respiratory Research (2026) 27:56  \n[https://doi.org/10.1186/s12931-025-03491-4](https://doi.org/10.1186/s12931-025-03491-4)  \nRespiratory Research  \nRESEARCH Open Access  \nActivating KRAS mutations mark premalignant cystic structures in congenital pulmonary airway malformations  \nCathy van Horik 1, Floor Benthem1,2, Marjon Buscop-van Kempen 1,2, Anne Boerema-de Munck1,2, Wilfred . F.J. van IJcken3, Rene . M. H. Wijnen 1, Marco. Schnater 1 and Robbert .J. Rottier 1,2*  \nAbstract  \nBackground Congenital Pulmonary Airway malformations (CPAM) may lead to malignant degeneration, and therefore many surgeons opt to resect CPAM even in asymptomatic patients. Previously, we identified Kirsten rat sarcoma virus (KRAS) mutations in a subset of CPAM patients, possibly indicating a pre-malignant state. In order to unify treatment strategy in (asymptomatic) patients we focused on KRAS mutations as a potential risk factor for developing malignancy in CPAM.  \nMethods Resected lung tissue of CPAM patients was separated in affected region (“cyst”) and non-affected region (“control”) to subsequently initiate airway organoids. Cyst and control organoids from the same patients with and without KRAS mutations (KRASPOS vs. KRASNEG) (n = 3) where processed for single cell RNA sequencing (scRNA-Seq), and the cellular composition of the organoids was validated by immunofluorescent staining. The role of KRAS was identified by manipulating the expression in the organoids.  \nResults ScRNA-Seq data revealed differences in cell proportions between KRASPOS and KRASNEG cyst, and control organoids. The significant differentially expressed genes in the KRASPOS cyst are comparable to those identified in lung cancer patients with KRAS mutations. Manipulation of KRAS expression showed that KRASPOS cyst organoids grew larger due to more proliferative cells and that KRAS directly affected the cell cycle.  \nConclusions KRASPOS cyst organoids show transcriptomic similarities with KRAS mutated lung cancers, show changes in cellular composition and have increased growth and proliferation. These findings support the hypothesis that KRAS mutated CPAM cysts belong to a group of CPAM patients at higher risk of developing a malignancy. Keywords Congenital pulmonary airway malformations, Organoids, KRAS, Mutations  \n*Correspondence:  \nRobbert .J. Rottier  \n[r. rottier@erasmusmc.nl](r. rottier@erasmusmc.nl)  \n1Department of Paediatric Surgery, Erasmus University Medical Centre, Sophia Children’s Hospital, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands  \n2Department of Cell and Developmental Biology, Erasmus University Medical Centre, Rotterdam, The Netherlands  \n3Center for Biomics, Erasmus University Medical Centre, Rotterdam, The Netherlands  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nHorik van et al. Respiratory Research (2026) 27:56  \nIntroduction  \nCongenital Pulmonary ","cbCaiituXSqJZeQc","https://ap.wps.com/l/cbCaiituXSqJZeQc","pdf",8025438,16,"English","# Abstract\n# Introduction\n## CPAM classification and incidence\n## Management controversy in asymptomatic patients","[{\"question\":\"Why do surgeons often resect CPAM lesions even in asymptomatic patients?\",\"answer\":\"CPAM may undergo malignant degeneration, so many surgeons opt for resection despite the absence of symptoms to reduce future cancer risk.\"},{\"question\":\"How was the study designed to assess KRAS as a risk factor in CPAM?\",\"answer\":\"Resected CPAM lung tissue was separated into cyst (affected) and control (non-affected) regions, followed by initiation of airway organoids. Organoids from patients with and without KRAS mutations were profiled using single-cell RNA sequencing and validated by immunofluorescent staining, with KRAS expression manipulation to determine functional effects.\"},{\"question\":\"What main findings link KRAS mutations to premalignant CPAM features?\",\"answer\":\"Single-cell RNA sequencing showed altered cell proportions in KRASPOS cyst organoids compared with KRASNEG, and differentially expressed genes resembled those in KRAS-mutant lung cancer. KRAS manipulation increased organoid growth by promoting proliferative cells and directly affected the cell cycle, supporting higher malignancy risk in KRAS-mutant CPAM cysts.\"}]","Activating KRAS mutations mark premalignant cystic structures in congenital pulmonary airway malformations | PDF",1790099257,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7849faffdaf7e24787c0fc75774916ac.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7731479fd1a0fcdfc0652e8fd16f520f.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/204840d604eb78cdc248caff772efbdf.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0e791555f40cdd6ca51303f845fa6a4c.webp",980,1306]